I am a
Home I AM A Search Login

Papers of the Week


Papers: 18 May 2019 - 24 May 2019


Human Studies, Pharmacology/Drug Development

PAIN TYPE:
Migraine/Headache


2019 Jul


Cephalalgia


39


8

Efficacy of galcanezumab in patients with chronic migraine and a history of preventive treatment failure.

Authors

Ruff DD, Ford JH, Tockhorn-Heidenreich A, Sexson M, Govindan S, Pearlman EM, Wang S-J, Khan A, Aurora SK
Cephalalgia. 2019 Jul; 39(8):931-944.
PMID: 31104507.

Abstract

Efficacy of galcanezumab in chronic migraine has been demonstrated in a pivotal Phase 3 study. Here, we assess efficacy in patients who have failed ≥2 and ≥1 prior migraine preventives for efficacy and/or safety reasons, and in those who never failed.